Novel Triazene Compounds For The Treatment Of Cancer
申请人:Reiter Rudolf
公开号:US20100234327A1
公开(公告)日:2010-09-16
The present invention relates to novel triazene compounds, to a process for their preparation, to pharmaceutical compositions comprising them, and to the use thereof in the treatment of cancer diseases in humans. The novel triazene compounds are distinguished, as compared with the known triazene compounds, by improved activity while at the same time having reduced toxicity, that is to say by fewer side-effects.